• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供体肝脂肪变性与肝移植后的结局:一项系统综述

Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

作者信息

Chu Michael J J, Dare Anna J, Phillips Anthony R J, Bartlett Adam S J R

机构信息

Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand,

出版信息

J Gastrointest Surg. 2015 Sep;19(9):1713-24. doi: 10.1007/s11605-015-2832-1. Epub 2015 Apr 28.

DOI:10.1007/s11605-015-2832-1
PMID:25917535
Abstract

BACKGROUND

There is increasing need to expand availability of donor liver grafts, including steatotic livers. Steatotic liver is associated with poor outcome post-transplantation but with conflicting results in the literature. The aim of this systematic review was to evaluate the impact of steatotic livers on liver transplantation outcomes.

METHODS

An electronic search of OVID Medline and Embase databases was performed to identify clinical studies that reported outcomes of steatotic livers in liver transplantation. Data were extracted, and basic descriptive statistics were used to summarise data pooled from individual clinical studies.

RESULTS

Ninety-two articles were identified, of which 34 met the inclusion criteria, and stratified analysis were performed. There was a lack of standardised definition of primary non-function or impaired primary function amongst the studies and description of type of steatosis. Severely (>60%) steatotic grafts are associated with increased risk of poor graft function, whilst moderate-severe (>30%) steatotic grafts are associated with decreased graft survival.

CONCLUSIONS

Available evidence showed increased risk of poor graft outcome in moderate-severe steatotic livers. A large prospective multi-centred trial will be required to identify the true risks of steatotic livers. Consistent definition of primary non-function/impaired primary function and description of type of steatosis is also required.

摘要

背景

扩大供体肝移植的可及性需求日益增加,包括脂肪变性肝脏。脂肪变性肝脏与移植后不良预后相关,但文献结果存在矛盾。本系统评价的目的是评估脂肪变性肝脏对肝移植结局的影响。

方法

对OVID Medline和Embase数据库进行电子检索,以识别报告肝移植中脂肪变性肝脏结局的临床研究。提取数据,并使用基本描述性统计方法总结从各个临床研究汇总的数据。

结果

共识别出92篇文章,其中34篇符合纳入标准,并进行了分层分析。研究中缺乏原发性无功能或原发性功能受损的标准化定义以及脂肪变性类型的描述。严重(>60%)脂肪变性移植物与移植物功能不良风险增加相关,而中重度(>30%)脂肪变性移植物与移植物存活率降低相关。

结论

现有证据表明,中重度脂肪变性肝脏的移植物不良结局风险增加。需要进行一项大型前瞻性多中心试验,以确定脂肪变性肝脏的真正风险。还需要对原发性无功能/原发性功能受损进行一致定义,并描述脂肪变性类型。

相似文献

1
Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.供体肝脂肪变性与肝移植后的结局:一项系统综述
J Gastrointest Surg. 2015 Sep;19(9):1713-24. doi: 10.1007/s11605-015-2832-1. Epub 2015 Apr 28.
2
Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.使用中度和重度脂肪变性供体肝脏进行肝移植的短期和长期结果:一项系统综述。
Medicine (Baltimore). 2018 Aug;97(35):e12026. doi: 10.1097/MD.0000000000012026.
3
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
4
Impact of ischaemic preconditioning on experimental steatotic livers following hepatic ischaemia-reperfusion injury: a systematic review.缺血预处理对肝缺血再灌注损伤后实验性脂肪变性肝脏的影响:一项系统评价
HPB (Oxford). 2015 Jan;17(1):1-10. doi: 10.1111/hpb.12258. Epub 2014 Apr 9.
5
Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.常温及低温机器灌注保存与静态冷藏在尸体供肾移植中的比较。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD011671. doi: 10.1002/14651858.CD011671.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Machine perfusion in liver transplantation.机器灌注在肝移植中的应用。
Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD014685. doi: 10.1002/14651858.CD014685.pub2.
8
Graft type for femoro-popliteal bypass surgery.股腘动脉搭桥手术的移植物类型。
Cochrane Database Syst Rev. 2018 Feb 11;2(2):CD001487. doi: 10.1002/14651858.CD001487.pub3.
9
Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: a systematic review.体外膜肺氧合在循环死亡供者腹部器官区域性灌注中的应用:系统评价。
Liver Transpl. 2013 Dec;19(12):1292-303. doi: 10.1002/lt.23771.
10
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.

引用本文的文献

1
An In-depth overview of artificial intelligence (AI) tool utilization across diverse phases of organ transplantation.人工智能(AI)工具在器官移植不同阶段的应用深度概述。
J Transl Med. 2025 Jun 18;23(1):678. doi: 10.1186/s12967-025-06488-1.
2
Impact of Preoperative Treatment on Donor Hepatic Steatosis in Living Donor Liver Transplantation.术前治疗对活体肝移植供体肝脂肪变性的影响
Ann Transplant. 2025 May 27;30:e947772. doi: 10.12659/AOT.947772.
3
Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function.纤维蛋白原氧化与血栓形成:塑造结构与功能

本文引用的文献

1
Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.利用供体/受者临床算法安全使用高度脂肪变性的肝脏。
Clin Transplant. 2013 Sep-Oct;27(5):732-41. doi: 10.1111/ctr.12211. Epub 2013 Sep 2.
2
Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.脂肪肝。我们可以在 OLTX 中使用它们吗?一项前瞻性基线肝活检研究的结果数据。
Ann Hepatol. 2012 Nov-Dec;11(6):891-8.
3
Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
Antioxidants (Basel). 2025 Mar 26;14(4):390. doi: 10.3390/antiox14040390.
4
Optimization of regions of interest sampling strategies for proton density fat-fraction MRI of hepatic steatosis before liver transplantation in ex vivo livers.离体肝脏肝移植前肝脂肪变性质子密度脂肪分数MRI感兴趣区采样策略的优化
Heliyon. 2024 Nov 19;11(4):e40146. doi: 10.1016/j.heliyon.2024.e40146. eCollection 2025 Feb 28.
5
Impact of liver graft steatosis on long-term post-transplant hepatic steatosis and fibrosis via magnetic resonance quantification.通过磁共振定量分析肝移植供肝脂肪变性对移植后长期肝脏脂肪变性和纤维化的影响。
Front Med (Lausanne). 2025 Jan 17;11:1502055. doi: 10.3389/fmed.2024.1502055. eCollection 2024.
6
Association between low fasting glucose of the living donor and risk of graft loss in the recipient after liver transplantation.活体供体空腹血糖水平低与肝移植受体移植物丢失风险之间的关联。
Sci Rep. 2025 Jan 6;15(1):951. doi: 10.1038/s41598-024-80604-x.
7
Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk.肝移植受者氧化应激诱导的纤维蛋白原修饰:揭示心血管风险的一种新的潜在机制
Res Pract Thromb Haemost. 2024 Aug 23;8(6):102555. doi: 10.1016/j.rpth.2024.102555. eCollection 2024 Aug.
8
Development of a portable device to quantify hepatic steatosis in potential donor livers.开发一种用于量化潜在供体肝脏肝脂肪变性的便携式设备。
Front Transplant. 2023 Jun 23;2:1206085. doi: 10.3389/frtra.2023.1206085. eCollection 2023.
9
Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study.供体移植肝脏在常温灌流下脱脂 - 一项随机临床试验:DeFat 研究方案。
Trials. 2024 Jun 17;25(1):386. doi: 10.1186/s13063-024-08189-4.
10
Steatotic Donor Transplant Livers: Preservation Strategies to Mitigate against Ischaemia-Reperfusion Injury.脂肪变性供体肝移植:减轻缺血再灌注损伤的保护策略。
Int J Mol Sci. 2024 Apr 24;25(9):4648. doi: 10.3390/ijms25094648.
脂肪变性供肝移植对肝细胞癌复发的影响:单中心经验
Hepatogastroenterology. 2012 May;59(115):858-62. doi: 10.5754/hge12007.
4
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.供体肝大泡性脂肪变性的等级比供体风险指数更能影响移植物和受者的预后。
J Gastroenterol Hepatol. 2012 Mar;27(3):540-6. doi: 10.1111/j.1440-1746.2011.06844.x.
5
Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.肝脂肪变性并不总是尸体肝移植的禁忌症。
HPB (Oxford). 2011 Jun;13(6):417-25. doi: 10.1111/j.1477-2574.2011.00310.x. Epub 2011 Apr 7.
6
High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.肝移植术后高级别微脂肪变性和肝功能延迟。
Hum Pathol. 2011 Sep;42(9):1337-42. doi: 10.1016/j.humpath.2010.12.004. Epub 2011 Mar 21.
7
Liver transplantation using fatty livers: always feasible?使用脂肪肝进行肝移植:总是可行的吗?
J Hepatol. 2011 May;54(5):1055-62. doi: 10.1016/j.jhep.2010.11.004. Epub 2010 Nov 13.
8
Short- and long-term outcomes after steatotic liver transplantation.脂肪变性肝脏移植后的短期和长期结果。
Arch Surg. 2010 Jul;145(7):653-60. doi: 10.1001/archsurg.2010.119.
9
The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.活检供体肝:将宏观脂肪变性纳入高危供体评估。
Liver Transpl. 2010 Jul;16(7):874-84. doi: 10.1002/lt.22085.
10
Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.肝移植前肝脂肪变性组织学评估中冰冻切片分析的预测价值。
Liver Transpl. 2009 Dec;15(12):1821-5. doi: 10.1002/lt.21948.